Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
DMC Global price target lowered to $59 from $64 at Stifel » 06:52
07/23/21
07/23
06:52
07/23/21
06:52
BOOM

DMC Global

$47.06 /

-3.16 (-6.29%)

Stifel analyst Stephen…

Stifel analyst Stephen Gengaro lowered the firm's price target on DMC Global to $59 from $64 after the company's Q2 EBITDA and revenues miss his expectations. While Gengaro called near-term guidance "disappointing" and thinks the shares likely weaken on the results, he keeps a Buy rating on DMC Global shares as he believes the medium-term story is intact and that the company will capture market share and price as demand trends higher.

ShowHide Related Items >><<
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

04/01/21 Roth Capital
Roth Capital sees DMC as under the radar beneficiary of Infrastructure Plan
02/19/21 Stifel
DMC Global price target raised to $67 from $53 at Stifel
02/17/21 Roth Capital
DMC Global price target raised to $50 from $34 at Roth Capital
09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

  • 05
    May
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

Thursday
On The Fly
Fly Intel: After-Hours Movers » 18:50
07/22/21
07/22
18:50
07/22/21
18:50
SNAP

Snap

$63.03 /

-0.345 (-0.54%)

, SKX

Skechers

$51.22 /

+0.93 (+1.85%)

, RHI

Robert Half

$86.55 /

-0.9 (-1.03%)

, TWTR

Twitter

$69.55 /

+0.03 (+0.04%)

, WRB

W. R. Berkley

$75.22 /

-1.27 (-1.66%)

, CE

Celanese

$148.89 /

-2.73 (-1.80%)

, TACO

Del Taco

$9.54 /

+0.18 (+1.92%)

, OCUL

Ocular Therapeutix

$12.12 /

-0.55 (-4.34%)

, SAM

Boston Beer

$954.75 /

+27.1 (+2.92%)

, BOOM

DMC Global

$47.06 /

-3.16 (-6.29%)

, VRSN

VeriSign

$233.40 /

+3.61 (+1.57%)

, COF

Capital One

$161.32 /

-1.885 (-1.16%)

, INTC

Intel

$55.97 /

-0.26 (-0.46%)

, ADVM

Adverum Biotechnologies

$3.07 /

-0.08 (-2.54%)

Check out this evening's…

ShowHide Related Items >><<
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

07/20/21 Jefferies
Twitter price target raised to $70 from $62 at Jefferies
07/20/21 Credit Suisse
Snap price target raised to $90 from $80 at Credit Suisse
07/15/21 JPMorgan
JPMorgan prefers Twitter over Snap into earnings
06/02/21 Cowen
Poshmark pent up demand for apparel should bode well, says Cowen
SKX Skechers
$51.22 /

+0.93 (+1.85%)

07/21/21 Cowen
Skechers price target raised to $55 from $50 at Cowen
07/20/21 Monness Crespi
Skechers upgraded to Buy from Neutral at Monness Crespi
07/15/21 Deutsche Bank
Skechers price target raised to $62 from $59 at Deutsche Bank
04/23/21 Williams Capital
Skechers guidance doesn't warrant current valuation, says Williams Trading
RHI Robert Half
$86.55 /

-0.9 (-1.03%)

04/26/21 Barclays
Robert Half price target raised to $95 from $85 at Barclays
04/22/21 Truist
Robert Half price target raised to $85 from $67 at Truist
04/22/21 Credit Suisse
Robert Half price target raised to $70 from $60 at Credit Suisse
04/22/21 Baird
Robert Half price target raised to $111 from $104 at Baird
TWTR Twitter
$69.55 /

+0.03 (+0.04%)

06/09/21 Vertical Group
Twitter upgraded to Very Positive from Mixed/Positive at Vertical Group
06/04/21 Mizuho
Twitter subscription service could drive 'modest' sales upside, says Mizuho
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

04/21/21 Deutsche Bank
W. R. Berkley price target raised to $80 from $70 at Deutsche Bank
04/07/21 Wells Fargo
W. R. Berkley initiated with an Overweight at Wells Fargo
02/24/21 UBS
W. R. Berkley upgraded to Buy from Neutral at UBS
02/24/21 UBS
W. R. Berkley upgraded to Buy from Neutral at UBS
CE Celanese
$148.89 /

-2.73 (-1.80%)

07/01/21
Fly Intel: Top five analyst upgrades
07/01/21 Deutsche Bank
Deutsche Bank upgrades Celanese to Buy on capital deployment
07/01/21 Deutsche Bank
Celanese upgraded to Buy from Hold at Deutsche Bank
06/21/21 Baird
Celanese remains a top pick at Baird
TACO Del Taco
$9.54 /

+0.18 (+1.92%)

03/09/21 CL King
Del Taco outpaced restaurant-level operating margin assumptions, says CL King
09/17/20 CL King
Del Taco price target raised to $13 from $11 at CL King
09/16/20 Jefferies
Del Taco price target raised to $10 from $8.50 at Jefferies
09/14/20 Piper Sandler
Del Taco price target raised to $8 from $7 at Piper Sandler
OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

07/21/21 RBC Capital
Boston Beer price target lowered to $1,466 from $1,538 at RBC Capital
07/16/21 Evercore ISI
Boston Beer price target lowered to $1,250 from $1,600 at Evercore ISI
07/12/21 Morgan Stanley
Boston Beer price target lowered to $1,450 from $1,530 at Morgan Stanley
07/09/21 Deutsche Bank
Boston Beer price target lowered to $1,074 from $1,280 at Deutsche Bank
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

04/01/21 Roth Capital
Roth Capital sees DMC as under the radar beneficiary of Infrastructure Plan
02/19/21 Stifel
DMC Global price target raised to $67 from $53 at Stifel
02/17/21 Roth Capital
DMC Global price target raised to $50 from $34 at Roth Capital
09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

04/23/21 Citi
VeriSign price target raised to $245 from $235 at Citi
12/09/20
Fly Intel: Top five analyst upgrades
12/09/20 JPMorgan
VeriSign upgraded to Overweight from Neutral at JPMorgan
COF Capital One
$161.32 /

-1.885 (-1.16%)

07/19/21 Odeon Capital
Capital One upgraded to Hold from Sell at Odeon Capital
07/12/21 Wells Fargo
Capital One price target raised to $180 from $155 at Wells Fargo
07/02/21 Credit Suisse
Capital One price target raised to $182 from $175 at Credit Suisse
07/02/21 Piper Sandler
Capital One price target raised to $170 from $169 at Piper Sandler
INTC Intel
$55.97 /

-0.26 (-0.46%)

07/21/21 Citi
Citi expects 'negative catalysts' from Intel's Q2 report
07/20/21 Susquehanna
Intel setup achievable given lowered bar, says Susquehanna
07/16/21 KeyBanc
Intel acquisition of GlobalFoundries would be 'positive,' says KeyBanc
07/15/21 Citi
AMD upgraded to Neutral from Sell at Citi
ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

07/09/21 Chardan
Adverum Biotechnologies coverage transferred at Chardan
05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform at SVB Leerink
05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform from Outperform at SVB Leerink
04/29/21 Chardan
Chardan downgrades Adverum after serious adverse reaction disclosure
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

  • 05
    May
  • 16
    Dec
  • 14
    Oct
  • 13
    Aug
TWTR Twitter
$69.55 /

+0.03 (+0.04%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

Earnings
DMC Global sees Q3 revenue $70M-$73M, consensus $73.24M » 16:19
07/22/21
07/22
16:19
07/22/21
16:19
BOOM

DMC Global

$47.06 /

-3.16 (-6.29%)

Michael Kuta, CFO, said…

Michael Kuta, CFO, said third quarter 2021 sales are expected to be in a range of $70M to $73 million versus the $65.4 million reported in the 2021 second quarter. DynaEnergetics expects demand from North America's onshore unconventional oil and gas market will continue to imprar. The growth is expected to be partially offset by lower sales in the Middle East. DynaEnergetics is expecove in the third quarter, although at a more moderate pace than in the first half of the yeted to report third quarter sales in a range of $46 million to $48 million versus the $42.3 million reported in 2021 second quarter. NobelClad's sales are expected in a range of $24 million to $25 million versus the $23.2 million reported in the 2021 second quarter. Consolidated gross margin is expected in a range of 24% to 26% versus 26% in the 2021 second quarter. The potential decline relates to the expected increase in North American sales versus higher margin international sales at DynaEnergetics, as well as inflationary pressures that will likely offset pricing increases. Gross margin at NobelClad also is expected to decline due to a less favorable project mix. Third quarter selling, general and administrative expense is expected to be in a range of $14.5 million to $15 million versus the $14.0 million reported in the 2021 second quarter. The increase reflects expected headcount additions for commercial and digital positions, higher variable compensation expense, and a pickup in travel expenses. Amortization expense is expected to be approximately $225,000, and interest expense is expected to be approximately $80,000. DMC's full year tax-rate is expected in a range of 31% to 33%. Adjusted EBITDA is expected in a range of $6.5 million to $8.5 million versus the $7.5 million in the second quarter of 2021.Third quarter capital expenditures are expected in a range of $4.0 million to $6.0 million. For modeling purposes, third quarter weighted average shares outstanding will be approximately 18.7 million. Kuta said management is not providing full-year financial guidance, however, pricing at DynaEnergetics is expected to improve during the second half of the year, which should offset the impact of inflation on materials, labor, and benefits from employee retention credits under the CARES Act that are expected to roll off in the fourth quarter of 2021.

ShowHide Related Items >><<
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

04/01/21 Roth Capital
Roth Capital sees DMC as under the radar beneficiary of Infrastructure Plan
02/19/21 Stifel
DMC Global price target raised to $67 from $53 at Stifel
02/17/21 Roth Capital
DMC Global price target raised to $50 from $34 at Roth Capital
09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

  • 05
    May
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

Earnings
DMC Global reports Q2 EPS 13c, consensus 13c » 16:16
07/22/21
07/22
16:16
07/22/21
16:16
BOOM

DMC Global

$47.06 /

-3.16 (-6.29%)

Reports Q2 revenue…

Reports Q2 revenue $65.4M, consensus $69.47M. Kevin Longe, president and CEO, said, "Improving economic conditions led to increased activity in several of our end markets during the second quarter. Rising energy prices drove improved demand for DynaEnergetics' DS well perforating systems, and NobelClad secured a large international order from the chemical industry." "DynaEnergetics benefitted from a modest improvement in pricing during the quarter," Longe added. "However, despite increased well completion activity in North America, irrational pricing for products and services persists, and is delaying the margin recovery of our industry. "The leading operators and service companies in North America's unconventional oil and gas industry are transitioning to safer, more efficient and more reliable factory-assembled perforating systems built by a single source provider. However, during the recent market instability, a number of machine shops have taken advantage of extreme price sensitivity by commercializing undifferentiated, less reliable carrier assemblies. These businesses are being supported and supplied by some of our industry's large energetics manufacturers, which have not yet fully transitioned to their own integrated systems."

ShowHide Related Items >><<
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

04/01/21 Roth Capital
Roth Capital sees DMC as under the radar beneficiary of Infrastructure Plan
02/19/21 Stifel
DMC Global price target raised to $67 from $53 at Stifel
02/17/21 Roth Capital
DMC Global price target raised to $50 from $34 at Roth Capital
09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

  • 05
    May
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

Upgrade
Craig-Hallum raises Veritone to Hold, sees PandoLogic greatly improving finances » 14:36
07/22/21
07/22
14:36
07/22/21
14:36
VERI

Veritone

$19.81 /

+1.11 (+5.94%)

As previously reported,…

As previously reported, Craig-Hallum analyst Chad Bennett upgraded Veritone to Hold from Sell with a price target of $20, up from $15, after the company announced an agreement to acquire PandoLogic for $150M. Veritone is "paying a remarkably low multiple" to add a recurring software business growing at a 100% compound annual growth rate with 50% EBITDA margin, said Bennett, who said the deal looks like it is "likely the most favorable transaction we have ever seen in software." While "cautiously optimistic" about the acquisition, he will need to see it play out to get real confidence in the potential pro-forma financials, added Bennett.

ShowHide Related Items >><<
VERI Veritone
$19.81 /

+1.11 (+5.94%)

VERI Veritone
$19.81 /

+1.11 (+5.94%)

07/22/21 Craig-Hallum
Veritone upgraded to Hold from Sell at Craig-Hallum
07/22/21 Roth Capital
PandoLogic deal 'adds a lot of opportunity' for Veritone, says Roth Capital
03/05/21 Northland
Veritone price target raised to $40 from $15 at Northland
03/05/21 Roth Capital
Veritone price target raised to $50 from $42 at Roth Capital
VERI Veritone
$19.81 /

+1.11 (+5.94%)

  • 03
    Dec
VERI Veritone
$19.81 /

+1.11 (+5.94%)

VERI Veritone
$19.81 /

+1.11 (+5.94%)

Upgrade
Veritone upgraded to Hold from Sell at Craig-Hallum » 14:30
07/22/21
07/22
14:30
07/22/21
14:30
VERI

Veritone

$19.81 /

+1.11 (+5.94%)

Craig-Hallum analyst Chad…

Craig-Hallum analyst Chad Bennett upgraded Veritone to Hold from Sell with a price target of $20, up from $15.

ShowHide Related Items >><<
VERI Veritone
$19.81 /

+1.11 (+5.94%)

VERI Veritone
$19.81 /

+1.11 (+5.94%)

07/22/21 Roth Capital
PandoLogic deal 'adds a lot of opportunity' for Veritone, says Roth Capital
03/05/21 Northland
Veritone price target raised to $40 from $15 at Northland
03/05/21 Roth Capital
Veritone price target raised to $50 from $42 at Roth Capital
03/05/21 JMP Securities
Veritone price target raised to $45 from $21 at JMP Securities
VERI Veritone
$19.81 /

+1.11 (+5.94%)

  • 03
    Dec
VERI Veritone
$19.81 /

+1.11 (+5.94%)

VERI Veritone
$19.81 /

+1.11 (+5.94%)

Recommendations
PandoLogic deal 'adds a lot of opportunity' for Veritone, says Roth Capital » 12:17
07/22/21
07/22
12:17
07/22/21
12:17
VERI

Veritone

$19.31 /

+0.61 (+3.26%)

Roth Capital analyst…

Roth Capital analyst Darren Aftahi said Veritone's deal to buy PandoLogic brings a new line of high-margin, SaaS revenue and "adds a lot of opportunity and cash flow." The price with earnouts of $150M "seems like a great value" from Veritone's side, added Aftahi, who has a Buy rating and $50 price target on Veritone shares.

ShowHide Related Items >><<
VERI Veritone
$19.31 /

+0.61 (+3.26%)

VERI Veritone
$19.31 /

+0.61 (+3.26%)

03/05/21 Northland
Veritone price target raised to $40 from $15 at Northland
03/05/21 Roth Capital
Veritone price target raised to $50 from $42 at Roth Capital
03/05/21 JMP Securities
Veritone price target raised to $45 from $21 at JMP Securities
02/23/21 Roth Capital
Veritone price target raised to $42 from $31 at Roth Capital
VERI Veritone
$19.31 /

+0.61 (+3.26%)

  • 03
    Dec
VERI Veritone
$19.31 /

+0.61 (+3.26%)

VERI Veritone
$19.31 /

+0.61 (+3.26%)

Recommendations
Truist 'not overly concerned' by Safehold earnings miss » 10:56
07/22/21
07/22
10:56
07/22/21
10:56
SAFE

Safehold

$84.00 /

-1.66 (-1.94%)

Truist analyst Ki Bin Kim…

Truist analyst Ki Bin Kim is "not overly concerned" by the earnings miss reported by Safehold, attributing it to "modeling nuances." Bin Kim says he did not model in the recent bond issuance, which makes up 2c of the miss, and he notes that revenue was lower than modeled despite Safehold executing on more deals than expected. This is likely a timing element of when the deals closed, which should resolve itself by next quarter, Bin Kim tells investors in a research note. He keeps a Hold rating on the shares with a $70 price target.

ShowHide Related Items >><<
SAFE Safehold
$84.00 /

-1.66 (-1.94%)

SAFE Safehold
$84.00 /

-1.66 (-1.94%)

06/23/21
Fly Intel: Top five analyst initiations
06/23/21 B. Riley
Safehold initiated with a Buy, $100 target at B. Riley
06/22/21 B. Riley
Safehold initiated with a Buy at B. Riley
03/30/21 Goldman Sachs
Safehold price target lowered to $95 from $112 at Goldman Sachs
SAFE Safehold
$84.00 /

-1.66 (-1.94%)

  • 11
    Nov
SAFE Safehold
$84.00 /

-1.66 (-1.94%)

Hot Stocks
VolitionRx's Nu.Q featured in two abstracts on COVID-19 severity prediction » 08:12
07/22/21
07/22
08:12
07/22/21
08:12
VNRX

VolitionRx

$3.10 /

+0.01 (+0.32%)

VolitionRx has been…

VolitionRx has been working with researchers at two NHS Foundation Trusts on two studies in COVID-19 for which abstracts were released at the International Society on Thrombosis and Haemostasis Congress 2021. Volition previously reported preliminary results demonstrating that its Nu.Q NETs assay correlated well with COVID-19 disease severity. The company now reports early-stage data with the same assay showing that results on admission could predict future COVID-19 disease severity and that serial results correlate with disease progression. The Nu.Q NETs biomarker results taken on hospital admission in this study correlated with COVID-19 disease severity and were predictive of whether patients required care in a general ward or organ support in an intensive care ward. The study results also indicated that elevated values of Nu.Q H3.1 could predict poor outcomes in patients admitted to Intensive Care.

ShowHide Related Items >><<
VNRX VolitionRx
$3.10 /

+0.01 (+0.32%)

VNRX VolitionRx
$3.10 /

+0.01 (+0.32%)

03/09/21 Cantor Fitzgerald
VolitionRx initiated with an Overweight at Cantor Fitzgerald
11/13/20 Oppenheimer
VolitionRx vet test could be bridge with human tests delayed, says Oppenheimer
VNRX VolitionRx
$3.10 /

+0.01 (+0.32%)

  • 10
    Feb
Hot Stocks
Veritone trading resumes  07:35
07/22/21
07/22
07:35
07/22/21
07:35
VERI

Veritone

$18.70 /

+0.77 (+4.29%)

 
ShowHide Related Items >><<
VERI Veritone
$18.70 /

+0.77 (+4.29%)

VERI Veritone
$18.70 /

+0.77 (+4.29%)

03/05/21 Northland
Veritone price target raised to $40 from $15 at Northland
03/05/21 Roth Capital
Veritone price target raised to $50 from $42 at Roth Capital
03/05/21 JMP Securities
Veritone price target raised to $45 from $21 at JMP Securities
02/23/21 Roth Capital
Veritone price target raised to $42 from $31 at Roth Capital
VERI Veritone
$18.70 /

+0.77 (+4.29%)

  • 03
    Dec
VERI Veritone
$18.70 /

+0.77 (+4.29%)

VERI Veritone
$18.70 /

+0.77 (+4.29%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.